News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. Peter Covitz Joins MDS Nordion (MDZ) as Senior Vice-President


2/6/2008 8:11:05 AM

OTTAWA, Feb. 5 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has appointed Dr. Peter Covitz to the newly created position of Senior Vice-President Innovation. Dr. Covitz will lead the global effort for developing and implementing new technology strategies and identifying new complimentary business opportunities to better serve customers and support growth at MDS Nordion.

"This new role demonstrates the value we place on engaging creative and dynamic thinkers and I'm thrilled Dr. Covitz is joining our team," said Steve West, President, MDS Nordion. "Acting as the primary scientific liaison, Dr. Covitz will advance our global innovation programs by identifying opportunities, setting up collaborations, and driving ideas to commercialization."

Dr. Covitz will report directly to Steve West, President of MDS Nordion and will be a member of the MDS Nordion Executive Management Team and a representative on the MDS Scientific Advisory Board.

Dr. Covitz comes to MDS Nordion from the National Cancer Institute (NCI) in Maryland, United States, where he held the position of Chief Operating Officer at the NCI's Center for Biomedical Informatics and Information Technology. He holds a Ph.D in Microbiology from Columbia University and a B.A. with a major in biology from Colgate University. Dr. Covitz holds a number of patents and is widely published in scientific journals.

About MDS Nordion

MDS Nordion (www.mdsnordion.com) is a world leader in medical isotopes, radiation and related technologies. It is a business unit of MDS Inc. . MDS is a global life sciences company that provides market-leading products and services our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS Inc. has more than 5,500 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

CONTACT: Media: Tamra Benjamin, Director Marketing and External
Communications, MDS Nordion, (613) 592-3400 ext. 1022,
tamra.benjamin@mdsinc.com; Investors: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS Inc.,
(416) 675-6777 x 34721, sharon.mathers@mdsinc.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES